Abstract: The present invention relates to a biaryl derivative compound, which exhibits the activity of a diacylglycerol acyltransferase 2 (DGAT2) inhibitor and is represented by chemical formula (1), a pharmaceutical composition comprising same as an active ingredient, and a use thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202317012603.pdf | 2023-02-24 |
| 2 | 202317012603-STATEMENT OF UNDERTAKING (FORM 3) [24-02-2023(online)].pdf | 2023-02-24 |
| 3 | 202317012603-REQUEST FOR EXAMINATION (FORM-18) [24-02-2023(online)].pdf | 2023-02-24 |
| 4 | 202317012603-PRIORITY DOCUMENTS [24-02-2023(online)].pdf | 2023-02-24 |
| 5 | 202317012603-POWER OF AUTHORITY [24-02-2023(online)].pdf | 2023-02-24 |
| 6 | 202317012603-FORM 18 [24-02-2023(online)].pdf | 2023-02-24 |
| 7 | 202317012603-FORM 1 [24-02-2023(online)].pdf | 2023-02-24 |
| 8 | 202317012603-DECLARATION OF INVENTORSHIP (FORM 5) [24-02-2023(online)].pdf | 2023-02-24 |
| 9 | 202317012603-COMPLETE SPECIFICATION [24-02-2023(online)].pdf | 2023-02-24 |
| 10 | 202317012603-certified copy of translation [31-05-2023(online)].pdf | 2023-05-31 |
| 11 | 202317012603-Proof of Right [11-08-2023(online)].pdf | 2023-08-11 |
| 12 | 202317012603-FORM 3 [11-08-2023(online)].pdf | 2023-08-11 |